Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Andreas Güntert"'
Autor:
Rufina Leung, Petroula Proitsi, Andrew Simmons, Katie Lunnon, Andreas Güntert, Deborah Kronenberg, Megan Pritchard, Magda Tsolaki, Patrizia Mecocci, Iwona Kloszewska, Bruno Vellas, Hilkka Soininen, Lars-Olaf Wahlund, Simon Lovestone
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e64971 (2013)
Markers of Alzheimer's disease (AD) are being widely sought with a number of studies suggesting blood measures of inflammatory proteins as putative biomarkers. Here we report findings from a panel of 27 cytokines and related proteins in over 350 subj
Externí odkaz:
https://doaj.org/article/9192672a6f704feeb27c108bea89de8d
Autor:
Abdul Hye, Alvina W.M. To, Malcolm Ward, Richard Killick, Anna Kinsey, John Powell, Anbarasu Lourdusamy, Simon Lovestone, Steven Lynham, Rufina Leung, Latha Velayudhan, Andreas Güntert
Publikováno v:
Journal of Alzheimer's Disease. 28:369-375
Diagnosis of the progressive neurodegenerative disorder Alzheimer's disease (AD) can only definitively be made postmortem. The most promising AD biomarkers identified to date are found in cerebrospinal fluid (CSF). Among these, one of the most intere
Autor:
Simon Lovestone, Andreas Güntert, Andrew J. Thompson, James Campbell, Helen Byers, Muzamil Saleem, Malcolm Ward, Darragh O'Brien
Publikováno v:
Journal of Alzheimer's Disease. 21:585-596
Alzheimer's disease (AD) is a progressive neurodegenerative disorder where definite diagnosis can only be made postmortem, and for which the most promising peripheral markers of disease state and severity have been found in the cerebrospinal fluid. H
Autor:
Liang Xiu, J. Tomeczkowski, Christoph Tapprich, Peter De Porre, Ansgar Lange, Joris Diels, P. Thilakarathne, Andreas Güntert
Publikováno v:
Advances in Therapy 32 (2015), Nr. 9
Advances in Therapy
Advances in Therapy
Introduction Among patients with acute myeloid leukemia (AML), the DACO-016 randomized study showed reduction in mortality for decitabine [Dacogen® (DAC), Eisai Inc., Woodcliff Lake, NJ, USA] compared with treatment choice (TC): at primary analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e582bd3ec4f973ff207423d427c235f1
http://www.repo.uni-hannover.de/handle/123456789/882
http://www.repo.uni-hannover.de/handle/123456789/882
Publikováno v:
Journal of Mass Spectrometry. 40:193-201
The accumulation and aggregation of the beta-amyloid peptide (Aβ) in the brain represents a key factor in the pathogenesis of Alzheimer's disease (AD). Many of the transgenic mouse models for AD exhibit an amyloid pathology with neuritic plaques but
Autor:
Rufina Leung, Loïc Dayon, Malcolm Ward, Karsten Kuhn, Andreas Güntert, Helen Byers, Darragh O'Brien, James B. Campbell, Simon Lovestone
Publikováno v:
Alzheimer's & Dementia. 7
Autor:
Andreas Güntert, Simon Lovestone, Christos Davatzikos, Anna Kinsey, Luigi Ferrucci, Susan M. Resnick, Muzamil Saleem, Deepthi Koka, Madhav Thambisetty, Michael A. Kraut, Yang An
Publikováno v:
NeuroImage. 59(1)
Recent genetic and proteomic studies demonstrate that clusterin/apolipoprotein-J is associated with risk, pathology, and progression of Alzheimer’s disease (AD). Our main aim was to examine associations between plasma clusterin concentration and lo
Autor:
Andreas Güntert, Petroula Proitsi, Simon J. Furney, Deborah Kronenberg, Hilkka Soininen, Magda Tsolaki, Christian Spenger, Bruno Vellas, Richard Dobson, Andrew Simmons, Simon Lovestone, Lars-Olof Wahlund, Iwona Kłoszewska, Patrizia Mecocci
Progression of people presenting with Mild Cognitive Impairment (MCI) to dementia is not certain and it is not possible for clinicians to predict which people are most likely to convert. The inability of clinicians to predict progression limits the u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a7d28d1083eeccf305d9b4cd78e3b7
http://hdl.handle.net/11391/1072865
http://hdl.handle.net/11391/1072865
Autor:
Mirsada Causevic, Christian Spenger, Hilkka Soininen, Sue Parkins, Magda Tsolaki, Susan M. Resnick, Malcolm Ward, Steven Lynham, Abdul Hye, Martin Broadstock, Paul T. Francis, Luigi Ferrucci, Yi Zhang, James Campbell, Angela Hodges, John Powell, Lars-Olof Wahlund, Gerome Breen, Patrizia Mecocci, Eric Westman, Bruno Vellas, Jill C. Richardson, Catherine Foy, Cathy Mitchelmore, Madhav Thambisetty, Petroula Proitsi, Declan G. Murphy, Simon J. Furney, Catherine Tunnard, Yun Zhou, Sally I. Sharp, Rufina Leung, Dean F. Wong, Andreas Güntert, Robert J. Williams, Alan C. Evans, Latha Velayudhan, David R. Howlett, Richard Killick, Anna Kinsey, Sebastian Muehlboeck, Simon Lovestone, Andrew Simmons, Darragh O'Brien, Katie Lunnon, Fahd Choudhry, Iwona Kłoszewska
Publikováno v:
Karolinska Institutet
CONTEXT: Blood-based analytes may be indicators of pathological processes in Alzheimer disease (AD). OBJECTIVE: To identify plasma proteins associated with AD pathology using a combined proteomic and neuroimaging approach. DESIGN: Discovery-phase pro
Autor:
Andrew Simmons, Andreas Güntert, Simon J. Furney, Patrizia Mecocci, Christian Spenger, Deborah Kronenberg, Simon Lovestone, H. Soininen, Megan Pritchard, Bruno Vellas, Iwona Kłoszewska, Rufina Leung, Lars-Olaf Wahlund, Magda Tsolaki
Publikováno v:
Alzheimer's & Dementia. 6